Reducing Involuntary Movements in Participants With Tardive Dyskinesia

NCT02198794 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Tardive Dyskinesia

Interventions

DRUG: SD-809
DRUG: Placebo

Sponsor

Auspex Pharmaceuticals, Inc.